SCHEMBL26931200

SCHEMBL26931200

CCOC(=O)c1cc(C(=O)c2ccc(F)cc2)n2c1ccc1cc(C)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 6/20 0.45
▸ FNTB P49356 6/20 0.45
▸ MAPT P10636 3/20 0.43
▸ NOD2 Q9HC29 3/20 0.42
▸ NOD1 Q9Y239 3/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TSHR P16473 1/20 0.40
▸ ELANE P08246 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26930708 0.93 NOD2 (0.47) FNTAFNTBMAPTNOD2NOD1
SCHEMBL30708803 0.93 NOD2 (0.47) FNTAFNTBMAPTNOD2NOD1
SCHEMBL26931128 0.89 FNTA (0.54) FNTAFNTBMAPTNOD2NOD1
SCHEMBL27165736 0.89 FNTA (0.54) FNTAFNTBMAPTNOD2NOD1
SCHEMBL26930792 0.89 FNTA (0.53) FNTAFNTBMAPTNOD2NOD1
SCHEMBL26930685 0.84 MAPT (0.39) FNTAFNTBMAPTNOD2NOD1
SCHEMBL27156308 0.80 NOD2 (0.48) FNTAFNTBNOD2NOD1KDM4E
SCHEMBL30708759 0.76 ALDH1A1 (0.44) FNTAFNTBMAPTNOD2NOD1
SCHEMBL26931196 0.76 ALDH1A1 (0.44) FNTAFNTBMAPTNOD2NOD1
SCHEMBL24749902 0.73 KDM4E (0.42) MAPTKDM4ELMNATSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11938120-B1 Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents King Faisal University (SA) 2024-03-26 — — US claimed
US-11938120-B1 Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents King Faisal University (SA) 2024-03-26 — — US disclosed
US-11845746-B1 Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents King Faisal University (SA) 2023-12-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11845746-B1 Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents BET1, RABGGTB, EP300 FNTA 962/4885FNTB 51/4885MAPT 2304/4885
US-11938120-B1 Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents BET1, RABGGTB, EP300 FNTA 1019/4885FNTB 59/4885MAPT 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback